AB 1124 | Workers’ Comp Executive | Workers’ Comp Executive

UR Reforms, Drug Formulary Boost Treatment Approvals

Recent reforms that established a prescription drug formulary for California’s workers’ comp system, and which created a utilization review exemption for many treatments rendered during the first 30 days of … Read More »

This content is only available to premium subscribers. Please login here log in

Formulary Committee Adds Cost Rationale To Drug Reviews

California’s evidence-based prescription drug formulary may soon add cost consideration to the process for selecting which drugs will qualify as exempt and which must go through utilization review. Members of … Read More »

This content is only available to premium subscribers. Please login here log in

America’s Opioid Crisis

The opioid crisis in America is not a recent development. It has as its genesis a wide range of causes, from efforts to treat chronic pain to diversion of drugs … Read More »

This content is only available to premium subscribers. Please login here log in

Flash Reports

🚨Update: Applied/CIC IS RENEWING AND WRITING NEW BUSINESS

📍New Mexico Balks at CIC Conservation Order

🚨Seized California Insurance Company (AppliedUnderwriters’)

CDI: Applied Merger Needed Prior Approval

Recent Articles

Travelers, CDI Heading To Court

Santa Clara Busts Another Voc Rehab Provider In Alleged Kickback Scheme

TRIA Reauthorization Bill Amended, Moving In Congress

State Defends Department’s $4.3M Fine Of MEWA

Employers Holdings’ Premium Drops

Tagged in: AB 1124

UR Reforms, Drug Formulary Boost Treatment Approvals

Formulary Committee Adds Cost Rationale To Drug Reviews

America’s Opioid Crisis